|
NIPSNAP3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01360031479203E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99279992086599E-10 |
| Normal-vs-Stage2 |
3.64240000000349E-05 |
| Normal-vs-Stage3 |
1.86100024279767E-11 |
| Normal-vs-Stage4 |
1.62814206561279E-12 |
| Stage1-vs-Stage2 |
9.072400E-01 |
| Stage1-vs-Stage3 |
2.200300E-02 |
| Stage1-vs-Stage4 |
6.12509999999844E-05 |
| Stage2-vs-Stage3 |
1.989450E-01 |
| Stage2-vs-Stage4 |
7.277900E-03 |
| Stage3-vs-Stage4 |
4.746200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.38458166943201E-14 |
| Normal-vs-AfricanAmerican |
1.436320E-03 |
| Normal-vs-Asian |
5.39300004653853E-09 |
| Caucasian-vs-AfricanAmerican |
4.715000E-01 |
| Caucasian-vs-Asian |
7.364400E-01 |
| AfricanAmerican-vs-Asian |
4.531600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.70810041058667E-11 |
| Normal-vs-Female |
1.37090339080714E-11 |
| Male-vs-Female |
4.530400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.46440000523296E-08 |
| Normal-vs-Age(41-60Yrs) |
3.55704354859654E-12 |
| Normal-vs-Age(61-80Yrs) |
2.62539989748234E-11 |
| Normal-vs-Age(81-100Yrs) |
1.924990E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.810000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.302100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.977800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.213000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.019600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.810400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.084800E-01 |
| Classical-VS-Follicular |
2.955600E-04 |
| Classical-VS-Other |
8.928800E-01 |
| Classical-VS-Normal |
1.63857816204427E-12 |
| Tall-VS-Follicular |
1.023930E-03 |
| Tall-VS-Other |
7.945800E-01 |
| Tall-VS-Normal |
2.6123999630201E-09 |
| Follicular-VS-Other |
2.191200E-01 |
| Follicular-VS-Normal |
2.138000E-03 |
| Other-VS-Normal |
1.876170E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33840050153822E-10 |
| Normal-vs-N1 |
6.54859499960025E-11 |
| N0-vs-N1 |
5.366500E-02 |
|
|
